Morphology, MYCN Amplification and their Correlation to Survival in Neuroblastoma Patients in India

被引：0
|
作者：
Srinivasan, R. [1 ,2 ]
Bhardwaj, N. [1 ]
Trehan, A. [3 ]
Rohilla, M. [2 ]
Bansal, D. [3 ]
机构：
[1] Postgrad Inst Med Educ & Res, Pathol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Pathol Cytol & Gynec Pathol Div, Chandigarh, India
[3] PGIMER, Paediat Hematol Oncol, Chandigarh, India
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV0156
引用
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [21] Centrosome amplification is correlated with ploidy divergence, but not with MYCN amplification, in neuroblastoma tumors
    Fukushi, Daisuke
    Watanabe, Naoki
    Kasai, Fumio
    Haruta, Masayuki
    Kikuchi, Akira
    Kikuta, Atsushi
    Kato, Koji
    Nakadate, Hisaya
    Tsunematsu, Yukiko
    Kaneko, Yasuhiko
    [J]. CANCER GENETICS AND CYTOGENETICS, 2009, 188 (01) : 32 - 41
  • [22] DISTINCT METASTATIC PATTERNS IN NEUROBLASTOMA ARE CORRELATED WITH MYCN AMPLIFICATION
    Bleeker, Gitta
    Caron, Huib N.
    van Eck-Smit, Berthe L. F.
    Versteeg, Rogier
    Kreissman, Susan G.
    Yanik, Gregory
    Tytgat, Godelieve A.
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1057 - 1058
  • [23] Whole chromosome alterations predict survival in high-risk neuroblastoma without MYCN amplification
    Bilke, Sven
    Chen, Qing-Rong
    Wei, Jun S.
    Khan, Javed
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (17) : 5540 - 5547
  • [24] Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
    Bray, Isabella
    Bryan, Kenneth
    Prenter, Suzanne
    Buckley, Patrick G.
    Foley, Niamh H.
    Murphy, Derek M.
    Alcock, Leah
    Mestdagh, Pieter
    Vandesompele, Jo
    Speleman, Frank
    London, Wendy B.
    McGrady, Patrick W.
    Higgins, Desmond G.
    O'Meara, Anne
    O'Sullivan, Maureen
    Stallings, Raymond L.
    [J]. PLOS ONE, 2009, 4 (11):
  • [25] WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma
    Masserot, Caroline
    Liu, Qingyuan
    Nguyen, Eric
    Gattolliat, Charles-Henry
    Valteau-Couanet, Dominique
    Benard, Jean
    Huber, Catherine
    Segal-Bendirdjian, Evelyne
    [J]. MOLECULAR ONCOLOGY, 2016, 10 (02) : 240 - 252
  • [26] Commentary on kaneko et al.:: Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification
    Brodeur, GM
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (08) : 608 - 609
  • [27] Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification
    Chen, BY
    Jhanwar, SC
    Ladanyi, M
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 2001, 10 (02) : 100 - 104
  • [28] Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
    G Schleiermacher
    J Michon
    I Huon
    C Dubois d'Enghien
    J Klijanienko
    H Brisse
    A Ribeiro
    V Mosseri
    H Rubie
    C Munzer
    C Thomas
    D Valteau-Couanet
    A Auvrignon
    D Plantaz
    O Delattre
    J Couturier
    [J]. British Journal of Cancer, 2007, 97 : 238 - 246
  • [29] Learning-Based Detection of MYCN Amplification in Clinical Neuroblastoma Patients: A Pilot Study
    Xiang, Xiang
    Zhang, Zihan
    Peng, Xuehua
    Shao, Jianbo
    [J]. MULTISCALE MULTIMODAL MEDICAL IMAGING, MMMI 2022, 2022, 13594 : 89 - 97
  • [30] Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
    Schleiermacher, G.
    Michon, J.
    Huon, I.
    d'Enghien, C. Dubois
    Klijanienko, J.
    Brisse, H.
    Ribeiro, A.
    Mosseri, V.
    Rubie, H.
    Munzer, C.
    Thomas, C.
    Valteau-Couanet, D.
    Auvrignon, A.
    Plantaz, D.
    Delattre, O.
    Couturier, J.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (02) : 238 - 246
12345